Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Drug inhibition of glycosyltransferases: Mycobacteria, including the species that causes tuberculosis (TB), synthesize a complex cell wall that helps to support and protect the bacterial cells. The major components of the cell wall include complex heteropolysaccharides that are synthesized in the periplasmic space. Zhang et al. determined the cryo–electron microscopy structures of two transmembrane glycosyltransferase enzyme complexes that use a lipid-anchored sugar donor to append arabinose units to the cell wall polysaccharides. They also captured the anti-TB drug ethambutol bound within these complexes and observed that it binds in a site overlapping both donor and acceptor sugars. Mapping of resistance mutants provides a structural understanding of how resistance emerges while preserving function of the enzyme and may help to guide the development of next-generation anti-TB drugs that target these enzymes. Science , this issue p. 1211
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
The Phyre2 web portal for protein modeling, prediction and analysis
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. E. (2015) · Nature Protocols · doi:10.1038/nprot.2015.053 · Cited by 9,652
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., et al. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798319011471 · Cited by 7,953
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
Automated electron microscope tomography using robust prediction of specimen movements
Mastronarde, D. N. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.07.007 · Cited by 5,336
UCSF ChimeraX: Meeting modern challenges in visualization and analysis
Goddard, T. D., Huang, C. C., Meng, E. C., Pettersen, E. F., Couch, G. S., Morris, J. H., & Ferrin, T. E. (2018) · Protein Science · doi:10.1002/pro.3235 · Cited by 5,267
Gctf: Real-time CTF determination and correction
Zhang, K. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.11.003 · Cited by 3,537
Cited by
Items 101–181 of 181
Yu, J., Lan, Y., Zhu, C., Chen, Z., Pan, J., Shi, Y., Yang, L., Hu, T., Gao, Y., Zhao, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59300-5 · Cited by 4
“The initial and fi nal con fi gurations as well as an intermediate con fi guration (t =36 ns) similar to IF asym-3 by one MD simulation were provided as Supplementary Data 3, 4, 5.”
Self-citationLi, D., Zhang, X., Yao, Y., Sun, X. J., Sun, J., Ma, X., Yuan, K., Bai, G., Pang, X., Hua, R., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412653121 · Cited by 5
“Anti - TB drugs such as SQ109, ethambutol, and bedaquiline have been developed against MmpL3, arabinosyltransferases, and ATP synthase, which reside on the membrane ( 20 , 22 , 23 ).”
InfluentialSelf-citationBiosynthetic incorporation for visualizing bacterial glycans
Marando, V. M., Kim, D. E., & Kiessling, L. L. (2022) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2021.12.005 · Cited by 6
Irma, J., Kartika, A., Rini, M., Setiohadji, B., & Salim, J. (2022) · Neuro-Ophthalmology · doi:10.1080/01658107.2022.2047207 · Cited by 4
Krishnan, A., Khan, F. I., Sukumar, S., & Khan, M. K. A. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2279699 · Cited by 4
Editorial: Host immune evasion by Mycobacterium tuberculosis: Current updates
Habtamu, M., Miheret, A., & Spurkland, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1102415 · Cited by 4
Risk‑Based Prediction of Novel AMR Variants Using Protein Language ModelsPreprint
Wood, J. J., Portelli, S., Ascher, D. B., & Furnham, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.12.672331 · Cited by 6
“In addition, ligand binding features were extracted using either existing crystal complex structures for EmbB-EMB (pdb id 7BVF) [27] and RpoB RNAP β-rifampicin (pdb id 5UHC) [28] or by generating docked complexes using auto dock vina [29] for PncA-pyrazinamide, KatG-isoniazid, Alr-cycloserine,…”
Future Research Directions on Mycobacterium tuberculosis Proteins
Farnia, P., Velayati, A. A., Ghanavi, J., & Farnia, P. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-96883-9_11 · Cited by 3
A new role for lipoproteins LpqZ and FecB in orchestrating mycobacterial cell envelope biogenesis
Lissner, R., Franklin, A., Benedict, S. T., Charitou, V., Speer, A., Knol, J. C., Jiménez, C. R., Moynihan, P. J., Nejentsev, S., Kuijl, C. P., et al. (2025) · mBio · doi:10.1128/mbio.02119-25 · Cited by 3
“Targets were predicted using CHOPCHOP (61) with PAM sequences NNAGAA, NNGGAA, and NNGGAG, and the first third of the gene of interest was targeted if possible.”
Mycobacterium avium : Diversity, Clinical Significance, Old and New Targeted Medicines
Nguyen, T. Q., Biet, F., Behr, M. A., & Kremer, L. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c01091 · Cited by 3
ag85A loss promotes free mycolate accumulation and sensitizes plasma membrane domain to disruption
Kado, T., Shivangi, Bosworth, P. H., Jordan, J., Freundlich, J. S., Siegrist, M. S., & Morita, Y. S. (2026) · Journal of Bacteriology · doi:10.1128/jb.00240-26 · Cited by 3
Kumar, L. M. S., Azeemuddin, M. M., Routhu, K. C., Priya, K., Babu, U. V., & Pai, K. S. R. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.118956 · Cited by 3
“Neither drug is known to interact with CYP enzymes, but there have been reports about other modes of interaction (Nishimura et al., 2004; Venkatesan, 1992; Zhang et al., 2014, 2020).”
BackgroundGéraud, N., Falcou, C., Parra, J., Froment, C., Rengel, D., Burlet‐Schiltz, O., Marcoux, J., Nigou, J., Rivière, M., & Fabre, É. (2023) · Glycobiology · doi:10.1093/glycob/cwad072 · Cited by 3
Kelly, S. D., Duong, N. H., Nothof, J. T., Lowary, T. L., & Whitfield, C. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402554121 · Cited by 3
Prediction of Mycobacterium tuberculosis cell wall permeability using machine learning methods
Banerjee, A., Sharma, A., Kamble, P., & Garg, P. (2024) · Molecular Diversity · doi:10.1007/s11030-024-10952-3 · Cited by 3
“This underscores the critical significance of cell wall production in the management of TB [8, 9].”
Carter, J. J. (2023) · Research Square · doi:10.21203/rs.3.rs-3378915/v1 · Cited by 3
“4D) 37 .”
Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growthPreprint
Qin, L., Xu, J., Chen, J., Wang, S., Zheng, R., Cui, Z., Liu, Z., Wu, X., Wang, J., Huang, X., et al. (2024) · eLife · doi:10.7554/elife.92737 · Cited by 4
Self-citationToit, A. D. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0411-2 · Cited by 2
Wang, Y., Wu, F., Fan, D., Lin, A., Xiang, L., Chen, Y., & Shao, J.-Z. (2025) · Journal of Virology · doi:10.1128/jvi.01387-25 · Cited by 4
Self-citationA Type VII-secreted toxin enables inter-mycobacterial competition
Benedict, S. T., Bowran, K., Lee, E. K., Reyre, J., Ahmad, H., Franklin, A., Mietrach, N., Han, C.-R., Chan, J. M., Layton, A. J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74429-7 · Cited by 3
Krentzel, D., Petit, J., Boudehen, Y., Mahtal, N., Sadowski, E., Zettor, A., Aubry, A., Chiaravalli, J., Aulner, N., Petrella, S., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeg6806 · Cited by 5
embB Gene association with Ethambutol drug Resistance in Mycobacterium Tuberculosis Patients
Hafeez, S., Sajid, H., Malik, F. Q., Zaidi, I. A., Niaz, S., & Iqtidar, A. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2115123273 · Cited by 2
Santamaria, G., Ruiz-Rodríguez, P., Renau-Mínguez, C., Pinto, F. R., & Coscollá, M. (2022) · Biomolecules · doi:10.3390/biom12030376 · Cited by 2
“The last step of this pathway, three reactions downstream WbbL2, is the target of the antimycobacterial drug ethambutol [43].”
BackgroundLiao, T.-C., Chen, C., Wang, M.-C., Ou, S., Tzen, J. T. C., & Yang, C.-Y. (2023) · Agronomy · doi:10.3390/agronomy13061476 · Cited by 2
Self-citationDeciphering the mannose transfer mechanism of mycobacterial PimE by molecular dynamics simulations
Bhattacharje, G., Ghosh, A., & Das, A. K. (2023) · Glycobiology · doi:10.1093/glycob/cwad096 · Cited by 2
Antibiotic Resistance in Mycobacteria
Zeng, J., Tan, X., & Gao, C. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007462 · Cited by 2
Amukti, D. P., Pratami, R. I., & Gumelar, G. (2024) · Journal of Pharmacy and Halal Studies · doi:10.70608/j8dmhg15 · Cited by 2
do Nascimento, D. D., Prado, L. D., Gonçalves, K. M., & de Magalhães, J. L. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n4-143 · Cited by 2
Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growthPreprint
Qin, L., Xu, J., Chen, J., Wang, S., Zheng, R., Cui, Z., Liu, Z., Wu, X., Wang, J., Huang, X., et al. (2024) · eLife · doi:10.7554/elife.92737.2 · Cited by 2
Self-citationSilva, R. S. F., de Almeida, J. S. F. D., & França, T. C. C. (2023) · Results in Chemistry · doi:10.1016/j.rechem.2023.101094 · Cited by 2
Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth
Qin, L., Xu, J., Chen, J., Wang, S., Zheng, R., Cui, Z., Liu, Z., Wu, X., Wang, J., Huang, X., et al. (2024) · eLife · doi:10.7554/elife.92737.3 · Cited by 1
Self-citationBasrai, A., Blundell, T. L., & Pandurangan, A. P. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26684 · Cited by 1
“In the case of katG , we identified resistance mutations associated with heme destabilization 12,18 as well as identifying mutations that destabi-lize isoniazid binding relatively more compared to heme.”
InfluentialElnady, R. E., Taha, E. A., Mortagi, Y. I., Amin, M. M., Taweel, M. M. E., Amer, A., & Zakaria, M. Y. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107748 · Cited by 1
Key Proteins and Enzymatic Mechanisms Underlying Drug Resistance in Mycobacterium tuberculosis
Farnia, P., Velayati, A. A., Ghanavi, J., & Farnia, P. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-96883-9_9 · Cited by 3
Structural basis of lipid-linked galactan export by the mycobacterial ABC transporter Wzm-Wzt
Garaeva, A. A., Fabianová, V., Savková, K., Huszár, S., Xue, X., Lowary, T. L., Mikušová, K., & Seeger, M. A. (2026) · Nature Communications · doi:10.1038/s41467-026-70429-9 · Cited by 1
“Arabinosyltransferases acting at the periplasm then attacharabinosylresiduesonthegalactanchainofLLG 9 .”
Encoded metabolic remodeling amplifies drug resistance in Mycobacterium tuberculosis
Frey, A. M., Babunovic, G. H., Culviner, P. H., Wang, X., Meirav, E., Gan, M., Zhu, J., Moody, D. B., Liu, Q., & Fortune, S. M. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014237 · Cited by 2
“…arabinose (DPA) – the carrier molecule for arabinose [45,46] – and the precursor to DPA, decaprenylphosphoryl ribose (DPR), it was proposed that the increased quantity of DPA allowed arabinose to outcompete ethambutol for binding to its drug target, the arabinosyltransferase EmbB [44,47,48].”
Gao, S., Wu, F.-Y., Zhang, Y., Batt, S. M., Wei, C., Wang, Z., Yang, X., Abrahams, K. A., Fütterer, K., Liu, X., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02317-8 · Cited by 1
“DPA is the key arabinose donor involved in Mtb cell wall arabinan synthesis for both arabinogalactan and lipoarabinomannan 14,16 .”
Self-citationResistance Mechanisms to First Line Drug in Mycobacterium tuberculosis: A Review
Hassan, J. S., Al-Tamimi, B. J., Abdulrahman, T. R., & Jamal, Q. W. (2022) · Iraqi journal of Medical Sciences · doi:10.22578/ijms.20.1.5 · Cited by 1
Structure and Function of Mycobacterial Arabinofuranosyltransferases
Tan, Y. Z., & Mancia, F. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-00793-4_12 · Cited by 2
Géraud, N., Riviere, C., Falcou, C., Cioci, G., Froment, C., Gervais, V., Marcoux, J., Gilleron, M., Nigou, J., Fabre, É., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08593-9 · Cited by 5
“However, these structures fall short of de fi ning the global binding mode of the acceptor substrate, although they highlighted the second largest soluble loop, namely EL4, as a key structural element in its recognition 29,75,78 – 81 .”
High Throughput Expression Screening of Arabinofuranosyltransferases from Mycobacteria
Rodrigues, J., Almeida, V. T., Rosário, A. L., Tan, Y. Z., Kloss, B., Mancia, F., & Archer, M. (2021) · Processes · doi:10.3390/pr9040629
“Interestingly, the structure of EmbC solubilized in DDM has been determined by X-ray crystallography [43].”
MethodANCORAGEM MOLECULAR DE FÁRMACOS E DERIVADOS COM PROTEÍNAS DA Mycobacterium tuberculosis
Sales, I. B., Oliveira, F., & Filadelfo, C. R. (2021) · Enciclopédia Biosfera · doi:10.18677/encibio_2021c3
Chemotherapy for Drug-Susceptible Tuberculosis
Singh, V., Cardoso, N. C., & Huszár, S. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_13
Khomyakov, Y. N., Zvyagintseva, D. D., & Khomyakova, T. I. (2023) · Epidemiology and Infectious Diseases · doi:10.17816/eid312900
Nanaware, R. B., Chabukswar, A. R., Tekade, V., Kashid, K., Vidhate, T., & Karmure, R. (2023) · Asian Journal of Chemical Sciences · doi:10.9734/ajocs/2023/v13i5257
Karn, V., Talati, V. P., Kamble, S. S., & Bastikar, V. A. (2023) · Asian Journal of Microbiology Biotechnology and Environmental Sciences · doi:10.53550/ajmbes.2023.v25i03.015
Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growthPreprint
Qin, L., Xu, J., Chen, J., Wang, S., Zheng, R., Cui, Z., Liu, Z., Wu, X., Wang, J., Huang, X., et al. (2024) · eLife · doi:10.7554/elife.92737.1
Self-citationTRATAMENTO FARMACOLÓGICO DA TUBERCULOSE POR ETAMBUTOL: UMA REVISÃO DE LITERATURA
Gomes, P. D. A., Brito, L. L. M., Brito, A. L. S., Alves, C. R., Sechi, G. R. A., Campos, T. G. S., & Jurema, H. C. (2024) · Revista Contemporânea · doi:10.56083/rcv4n1-113
Ray, L. F. L. (2021) · theses.fr (ABES) · doi:10.70675/71d68700z0ba8z4252z9a52z7f5bb2bb44ab
Qin, L., Xu, J., Chen, J., Wang, S., Zheng, R., Cui, Z., Liu, Z., Wu, X., Wang, J., Huang, X., et al. (2024) · eLife · doi:10.7554/elife.92737.3.sa3
Self-citationKrishnan, A., Khan, F. I., Sukumar, S., Booja, C. S., Ota, M., & Khan, M. K. A. (2025) · ChemistrySelect · doi:10.1002/slct.202404932
Fang, D., Su, B., Cheng, G., Wang, Q., Lan, K., Wang, H., Zhou, P., Bi, Y., Liu, C., Dou, D., et al. (2025) · 中国科学基金 · doi:10.3724/bnsfc-2024.12.15.0002
Self-citationPopova, A. V., Bykova, D. I., Fedonin, G. G., Bosov, D. V., Reshetnikov, K., & Neverov, A. D. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf264
Schumann, N. C., Shamma, F., Brooks, C. L., Johnson, S., Yim, M., Olsen, K. J., Peña, K., Karakousis, P. C., Abell, A. D., & Goldfarb, N. E. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100311
Eisenhaber, B., Sinha, S., Jadalanki, C. K., Shitov, V. A., Tan, Q. W., Sirota, F. L., & Eisenhaber, F. (2021) · Figshare · doi:10.6084/m9.figshare.13565811
Bwalya, P. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.14943/doctoral.k15047
Harrison, S. H. (2024) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Kumar, D., Bhoomika, & Dangi, M. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100225
Over-expression, purification, and kinetic analysis of Mycobacterium tuberculosis WecA
Zhao, Y., Jia, H., Wang, Y., Sha, S., An, D., Yang, S., Qian, L., Ma, Y., & Xu, L. (2026) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2025.2610028
Self-citationDefining the Mechanism of Action and Resistance of New Mycobacterium abscessus MmpL3 Inhibitors
Abdalla, B. J., Giletto, M. B., Carpa, N. G., Wilson, A. K., Ellsworth, E. L., & Abramovitch, R. B. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.5c00709 · Cited by 2
CRISPR‐based genome editing reveals the roles of efflux pumps in Mycobacterium abscessus
Li, S., Duan, A., Zhang, L., Wang, C., Yan, M., Ren, G., Pan, L., & Sun, Y.-C. (2026) · mLife · doi:10.1002/mlf2.70048
“Since Ethambutol (EMB) is another drug targeting cell wall biosynthesis 29 , we evaluated the effects of both ETH and EMB on the transformation ef fi ciency of M. abscessus .”
Self-citationMutations in the ubiA gene are the major mechanism of ethambutol resistance in Mycobacterium avium
Qiu, Y., Dong, X., Cao, D., Jiang, X., Ji, Z., Xu, P., Li, Y., Xu, K., & Zhang, Y. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03151-25
“Previous studies indicate that in strains with a wild-type ubiA genotype, EMB inhibits EmbCAB activity, thereby disrupting cell wall integrity and resulting in bacterial (28, 29).”
Mechanistic insights into corynebacterial divisome complexes involved in cell septation
Gaday, Q. (2022) · theses.fr (ABES) · doi:10.70675/1b902613z368bz4173zab5ez904438ab73d1 · Cited by 1
The SUF Machinery from Mycobacterium tuberculosis as a new target for anti-tubercular drugs
Elchennawi, I. (2024) · theses.fr (ABES) · doi:10.70675/10d8c735zda57z4935z8973z81c71d13f3cb · Cited by 1
Naylor, C., Prosser, G. A., Bayliss, T., Berle, L., Wallach, J. B., Kim, H., Olvera, R. A., Thompson, S., Ioerger, T. R., Simpson, L., et al. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00123 · Cited by 1
Combating Mycobacterial Infections: An Overview of Therapeutic Strategies
Shaji, A., Bhaskar, A., Dwivedi, V. P., & Singh, A. (2026) · Springer eBooks · doi:10.1007/978-981-92-0256-0_1
Osugi, A., Fujiwara, K., Ito, M., Kurahara, Y., Morimoto, K., & Mitarai, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.23.727351
“Its protein products, the EmbA/EmbB heterodimers and EmbC/EmbC homodimers, catalyze the synthesis of their mycobacteria-specific cell wall components, mycolyl-arabinogalactan-peptidoglycan and lipoarabionomannan, respectively (7,8).”
Engineered nanoparticles for mitigating nervous system infections
Negahdary, M., Verma, S. S., & Draz, M. S. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.218202
Liu, X., Ling, X., Wang, K., Zheng, J., Li, H., Guo, M., Ou, Y., Lu, J., & Li, W. (2026) · Microorganisms · doi:10.3390/microorganisms14071579
“EMB, another antituberculosis drug, inhibits the synthesis of another cell wall component, arabinogalactan [41].”
Pee, C. J. E., Santos, M. D., & Pethe, K. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00309
Polepalli, S., Roy, A., Mondal, B., Singh, A., & Dutta, S. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154013
Combating Drug‐Resistant Tuberculosis: Advancements in Diagnostics and Therapeutics
Gautam, S., Saini, J., Begum, J. P. S., Sharma, D., & Venugopal, D. (2026) · Pulmonary Medicine · doi:10.1155/pm/3346306
“A mutation in the embB gene at Position 306 could represent another explanation of the EMB resistance, which is caused by the substitution of methionine with leucine or isoleucine [33].”
Illouz, M., Wasselin, V., Pál, A., Lewis, C., Foubert, M., Briand, A., Malmsheimer, S., Chalut, C., Korduláková, J., Hatfull, G. F., et al. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00626 · Cited by 1
Recognition and mechanism of M. tuberculosis cell wall galactan transport
Wei, C., Abrahams, K. A., Krisilia, V., Li, J., Gurcha, S. S., Derr, E., Hänisch, M., Kalscheuer, R., Besra, G. S., Rao, Z., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-78496-8
“The arabinan pathway has long been established as an attractive anti-TB drug target, as exempli fi ed by the front-line drug ethambutol and new nitroimidazole drugs pretomanid/ delamanid, which target the EmbA/B/C and DprE2 proteins, respectively 29,30 .”
Self-citationBindingDB (2022) · UC San Diego · doi:10.7270/q2rv0sch
Rajput, S., Kumar, A., Banjara, P., Sharma, P., & Das, G. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.109213
Comprehensive mapping of essential-gene interactions in M. tuberculosis
Kresse, I. J., Sayegh, N. Y., Munsamy, V., Na, A., Nitz, S., Ozakman, Y., Bosch, B., Behn-Eschenburg, S. G., Poulton, N. C., Reddy, A. K., et al. (2026) · Nature · doi:10.1038/s41586-026-11212-0
Opportunities and Challenges in Clinical and Preclinical Drug Development for Mycobacterium marinum
Jing, Q.-Q., Wang, W., Zhang, Q., Xu, T., Wei, M., & Shao, C. (2026) · Medicinal Research Reviews · doi:10.1002/med.70126
Self-citation
Metadata
- Authors
- Zhang, L., Zhao, Y., Gao, Y., Wu, L., Gao, R., Zhang, Q., Wang, Y., Wu, C., Wu, F., Gurcha, S. S., Veerapen, N., Batt, S. M., Zhao, W., Qin, L., Yang, X., Wang, M., Zhu, Y., Zhang, B., Bi, L., Zhang, X., Yang, H., Guddat, L. W., Xu, W., Wang, Q., Li, J., Besra, G. S., & Rao, Z.
- Affiliations
- Nankai University (CN)
- Chinese Academy of Sciences (CN)
- Tsinghua University (CN)
- ShanghaiTech University (CN)
- State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Response, College of Life Sciences, College of Pharmacy, Nankai University, Tianjin 300353, China.
- University of Birmingham (GB)
- The University of Queensland (AU)
- ORCID
- Venue
- Science
- Published
- 2020-06-12
- Volume
- 368
- Issue
- 6496
- Pages
- 1211-1219
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3020603994
- Cited by
- 173
- References
- 61
- Citations by year
- 2026: 24 · 2025: 39 · 2024: 28 · 2023: 31 · 2022: 22 · 2021: 20 · 2020: 9
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- DORA PSI (Paul Scherrer Institute) (submittedVersion)
- Funders
- National Medical Research Council (MR/S000542/1)
- National Key Research and Development Program of China Stem Cell and Translational Research (2017YFC0840300)
- Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29020000)
- Project of International Cooperation and Exchanges NSFC (81520108019)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Polysaccharides and Plant Cell Walls
- Keywords
- ethambutol, Mycobacterium tuberculosis, drug resistance, cell wall polysaccharides, enzyme-inhibitor binding, antitubercular agents, cryo-EM structure
- MeSH terms
- Antitubercular Agents, Cell Wall, Ethambutol, Mycobacterium tuberculosis, Pentosyltransferases, Protein Conformation, Cryoelectron Microscopy, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.